Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

التفاصيل البيبلوغرافية
العنوان: Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia
المؤلفون: Charles L. Spurr, Richard T. Eagan, John B. Harley, Johannes Blom, James H. Holland, Levy Rn, Robert A. Kyle, Oliver Glidewell, Janet Cuttner, Robert W. Carey, Manuel Ribas-Mundo, R R Ellison, Farid I. Haurani, Stanley T. Lee, John H. Moon, Richard T. Silver
المصدر: Cancer. 36:1560-1566
بيانات النشر: Wiley, 1975.
سنة النشر: 1975
مصطلحات موضوعية: Cancer Research, Daunorubicin, business.industry, Pharmacology, Mercaptopurine, chemistry.chemical_compound, Pharmacotherapy, Oncology, chemistry, medicine, Myelocytic leukemia, business, Cytosine, Median survival, medicine.drug
الوصف: Three hundred twenty-six patients with acute myelocytic leukemia were randomly and prospectively assigned to four therapeutic regimens: cytosine arabinoside either alone or in combination with daunorubicin, 6-mercaptopurine, or 6-thioguanine. The results in 231 qualified previously untreated patients were analyzed. The combination treatments produced a significantly greater frequency of complete or partial remission than single drug therapy. Treatment with cytosine arabinoside and thioguanine led to 48% age-adjusted complete and partial responses. The median sur survival from diagnosis of all 66 evaluable patients treated with these two drugs was 18 weeks, while the median survival for those who responded to this combination was 15 months.
تدمد: 1097-0142
0008-543X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::010dd6fb90000eea3630c0d61ebd3e63
https://doi.org/10.1002/1097-0142(197511)36:5<1560::aid-cncr2820360504>3.0.co;2-5
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........010dd6fb90000eea3630c0d61ebd3e63
قاعدة البيانات: OpenAIRE